1. Home
  2. GOLF vs ERAS Comparison

GOLF vs ERAS Comparison

Compare GOLF & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acushnet Holdings Corp.

GOLF

Acushnet Holdings Corp.

HOLD

Current Price

$85.62

Market Cap

5.1B

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$10.25

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOLF
ERAS
Founded
1910
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.5B
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
GOLF
ERAS
Price
$85.62
$10.25
Analyst Decision
Hold
Strong Buy
Analyst Count
7
12
Target Price
$83.67
$14.25
AVG Volume (30 Days)
320.6K
8.6M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
36.23
EPS
1.36
N/A
Revenue
$1,633,721,000.00
N/A
Revenue This Year
$5.76
N/A
Revenue Next Year
$2.44
N/A
P/E Ratio
$63.16
N/A
Revenue Growth
4.71
N/A
52 Week Low
$67.14
$1.06
52 Week High
$104.81
$24.28

Technical Indicators

Market Signals
Indicator
GOLF
ERAS
Relative Strength Index (RSI) 36.35 36.23
Support Level $78.60 $2.07
Resistance Level $86.07 $16.14
Average True Range (ATR) 3.30 0.88
MACD -1.01 -0.21
Stochastic Oscillator 11.64 59.45

Price Performance

Historical Comparison
GOLF
ERAS

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: